Winfast Holding logo

Winfast Holding

Asia, Jiangsu, China, Nanjing

Description

Winfast Holding is a fund-management & investment group.

Investor Profile

Winfast Holding has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (25%)
  • Series D (25%)
  • Series C (25%)
  • Series B (25%)

Country Focus

  • China (100%)

Industry Focus

  • Health Care
  • Medical
  • Biopharma
  • Biotechnology
  • Pharmaceutical
  • Battery
  • Energy
  • Energy Management
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Winfast Holding frequently co-invest with?

Puhua Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Linden Asset
Asia, Shanghai, China, Shanghai
Co-Investments: 1
NC
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CITIC Capital Holdings
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Hefei Innovation Investment
Asia, Anhui, China, Hefei
Co-Investments: 1
Advantage Capital
North America, Louisiana, United States, New Orleans
Co-Investments: 1
CMB International Capital Corporation
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 2
Xizi United Holdings
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Founder H Fund
Asia, Beijing, China, Beijing
Co-Investments: 1
Yingke Capital
Asia, Jiangxi, China, Fuzhou
Co-Investments: 2

What are some of recent deals done by Winfast Holding?

Huasun Energy

Hefei, Anhui, China

Huasun Energy specializes in the production, and sales of high-efficiency silicon heterojunction cells and components.

BatteryEnergyEnergy Management
Series ANov 1, 2021
Hanyu Medical

Shanghai, Shanghai, China

Hanyu Medical is a transcatheter mitral valve repair equipment supplier.

Health CareMedicalMedical Device
Series DMar 15, 2021
Amount Raised: $76,924,260
Ark Biosciences

Shanghai, Shanghai, China

Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development

BiopharmaBiotechnologyHealth CarePharmaceutical
Series CJan 22, 2021
Amount Raised: $86,000
Haihe Biopharma

Shanghai, Shanghai, China

Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BJul 24, 2020
Amount Raised: $171,005,942